Hospital
Mena Hospital Commission
Mena Hospital Commission was paid $1.87M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 11% of everything it billed.
33Billing provider infoMENA HOSPITAL COMMISSION
MENA, AR 71953
MENA, AR 71953
33aNPI1861449639assigned 05/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.87M
24GClaims151,932
24DCodes billed124
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arkansas
Rank by total paid#28 of 49
Median peer was paid$2.62M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,268 | $247K | |
| 2019 | 25,688 | $340K | |
| 2020 | 22,692 | $252K | |
| 2021 | 20,761 | $266K | |
| 2022 | 25,434 | $273K | |
| 2023 | 21,486 | $265K | |
| 2024incomplete | 16,603 | $232K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 11% | 16,166 | 12,041 | $205K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10% | 1,541 | 1,315 | $190K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9.6% | 6,199 | 1,510 | $180K |
| 70450 | Computed tomography, head or brain; without contrast material | 9.1% | 2,038 | 1,698 | $171K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.5% | 1,094 | 1,011 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.7% | 17,632 | 13,123 | $88K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.4% | 1,049 | 886 | $64K |
| 80050 | General health panel | 2.4% | 964 | 932 | $44K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.2% | 1,244 | 813 | $41K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.1% | 935 | 867 | $39K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 3,741 | 2,958 | $30K |
| 83880 | 1.6% | 2,114 | 1,631 | $30K |
112 more codes
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.5% | 152 | $28K |
| 82553 | 1.5% | 3,146 | $28K | |
| 80306 | 1.4% | 1,869 | $27K | |
| 99283 | Emergency room visit (moderate) | 1.4% | 1,525 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 4,395 | $26K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 4,218 | $26K |
| 99284 | Emergency room visit (serious) | 1.3% | 1,196 | $25K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,337 | $22K |
| 84484 | 1.2% | 3,546 | $22K | |
| 80061 | Lipid panel | 1.1% | 2,242 | $21K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 14,821 | $20K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.1% | 2,872 | $20K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 993 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,879 | $17K |
| 87088 | <1% | 2,837 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,529 | $16K |
| 82550 | <1% | 3,195 | $16K | |
| 81003 | <1% | 6,439 | $16K | |
| 84439 | <1% | 2,302 | $15K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 206 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 94 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,107 | $11K |
| 83690 | <1% | 1,717 | $11K | |
| 87040 | <1% | 759 | $10K | |
| 81025 | <1% | 1,365 | $10K | |
| 85730 | <1% | 2,342 | $9K | |
| 73610 | <1% | 564 | $9K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 541 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 868 | $8K |
| 85610 | <1% | 3,015 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,891 | $8K |
| 73030 | <1% | 424 | $7K | |
| 87420 | <1% | 608 | $7K | |
| 82150 | <1% | 1,104 | $7K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 470 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,240 | $6K |
| 73562 | <1% | 274 | $6K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 123 | $6K |
| 73630 | <1% | 263 | $6K | |
| 83605 | <1% | 624 | $5K | |
| 86140 | <1% | 1,070 | $5K | |
| 87070 | <1% | 557 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 540 | $5K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 476 | $5K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 284 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 624 | $4K |
| 85379 | <1% | 468 | $4K | |
| 87077 | <1% | 656 | $4K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 84 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 873 | $3K |
| 83550 | <1% | 457 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 825 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 225 | $3K |
| 73110 | <1% | 178 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 872 | $3K |
| 73130 | <1% | 158 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 29 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 36 | $3K |
| 97161 | <1% | 42 | $3K | |
| 82607 | <1% | 237 | $3K | |
| 72100 | <1% | 146 | $3K | |
| 82040 | <1% | 1,344 | $2K | |
| 83540 | <1% | 474 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 82 | $2K |
| 87186 | <1% | 546 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 77 | $2K |
| 85652 | <1% | 863 | $2K | |
| 80055 | <1% | 68 | $2K | |
| 71020 | <1% | 130 | $2K | |
| 83735 | <1% | 300 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 69 | $1K |
| 84481 | <1% | 81 | $1K | |
| 82746 | <1% | 101 | $1K | |
| 87400 | <1% | 145 | $1K | |
| 73502 | <1% | 62 | $1K | |
| 90837 | Psychotherapy session, about an hour | <1% | 17 | $1K |
| 82728 | <1% | 82 | $914.62 | |
| 73564 | <1% | 55 | $813.45 | |
| 82805 | <1% | 26 | $810.40 | |
| 71010 | <1% | 118 | $800.00 | |
| 82947 | <1% | 168 | $656.50 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $651.56 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $651.56 |
| 85027 | <1% | 133 | $558.81 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 16 | $537.06 |
| 86703 | <1% | 37 | $508.12 | |
| 85014 | <1% | 193 | $473.86 | |
| 82950 | <1% | 67 | $393.44 | |
| 80320 | <1% | 30 | $361.92 | |
| 85018 | <1% | 166 | $358.38 | |
| 82565 | <1% | 13 | $353.26 | |
| 87449 | <1% | 37 | $334.62 | |
| 86901 | <1% | 31 | $315.00 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 23 | $309.30 |
| 83655 | <1% | 16 | $249.20 | |
| 90714 | <1% | 27 | $196.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 103 | $163.95 |
| 84702 | <1% | 18 | $138.48 | |
| 87045 | <1% | 12 | $114.70 | |
| 85007 | <1% | 39 | $103.32 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 72 | $98.07 |
| 86850 | <1% | 57 | $85.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 51 | $71.10 |
| 86900 | <1% | 31 | $38.34 | |
| 84156 | <1% | 12 | $36.75 | |
| 87046 | <1% | 12 | $33.70 | |
| J3490 | Unclassified drugs | <1% | 32 | $13.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 48 | $10.88 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 18 | $8.01 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 64 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 79 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOOD, MICHAEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| City of Plattsmouth | Plattsmouth, NE | $86K |
| The Eye Clinic, INC. | Massillon, OH | $22K |
| Renaissance Women's Center | Conway, AR | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.